This is a monthly Grand Rounds to help educate our Urology Faculty, Residents, Allied Healthcare Providers, and Community Physicians. It is designed around Urologic topics to assist in updated medical topics and care.
Provide timely updated education to a wide spectrum on current urologic topics and controversies. The information provided by our speakers is intended to enhance basic knowledge on fundamental principles in urology and broaden the scope of knowledge on more focused topics. Speakers and topics are chosen based upon their relevance to current needs put forth by the audience as well as updates to current guidelines and controversies.
Adult Urologic disease cover a broad spectrum of topics, which are treatmed by a wide assortment of providers. Staying current on a variety of changing controversies and refreshing knowledge on core competencies is critical to maintaining an excellence in care. Additionally, our grand rounds help to educate and train our residents and broaden their educational exposure.
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation:
The Medical College of Wisconsin designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
- Urology Faculty
- Allied Healthcare Providers
- Community Physicians
At the conclusion of this activity, I will be able to:
- The participant will understand current surgical strategies for treatment of Wilms tumor and to identify which patients would be candidates for partial vs. radical nephrectomy.
- The participant will understand diagnostic and staging tests necessary to differentiate childhood renal tumors, determine prognosis, and plan for surgery. This includes an understanding of the two prevailing and divergent staging and management algorithms, including their inherent advantages and disadvantages.
- The participant will understand the genetic and molecular basis for Wilms tumor and how innovations in this field are leading to improved prognostication and treatment of Wilms tumor.
Faculty & credentials:
Role in Meeting:
Ken Jacobsohn, MD
William See, MD
Gina Lockwood, MD
All persons in control of content have no relevant financial relationships to disclose with the exception of the following person:
+1 (414) 805-0788
03/06/2015 - 7:30am to 8:30am CST
Zablocki VA Medical Center in Auditorium
5000 W National Avenue
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.